| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1473-3099(13)70267-6 |
| P698 | PubMed publication ID | 24268590 |
| P50 | author | Joseph Bresee | Q61189679 |
| Larisa Gubareva | Q66732793 | ||
| Alicia M Fry | Q87077992 | ||
| Stephen Luby | Q39062628 | ||
| P2093 | author name string | Mustafizur Rahman | |
| Kamrun Nahar | |||
| W Abdullah Brooks | |||
| Doli Goswami | |||
| Tasnim Azim | |||
| Amina Tahia Sharmin | |||
| P2860 | cites work | Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections | Q39437895 |
| Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. | Q39820157 | ||
| Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group | Q40625504 | ||
| Viral Shedding Patterns of Children with Influenza B Infection | Q40866334 | ||
| Outcomes of adults hospitalised with severe influenza. | Q43044944 | ||
| Viral loads and duration of viral shedding in adult patients hospitalized with influenza. | Q43873120 | ||
| The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971 | Q43888118 | ||
| Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. | Q45974600 | ||
| Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. | Q48719424 | ||
| Patterns of Shedding of Myxoviruses and Paramyxoviruses in Children | Q72915423 | ||
| Should staff in long-stay hospitals for elderly patients be vaccinated against influenza? | Q73449663 | ||
| Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment | Q30304330 | ||
| Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir | Q30306773 | ||
| Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. | Q30350180 | ||
| Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States | Q30388312 | ||
| Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays | Q30390818 | ||
| Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. | Q30471016 | ||
| Oral oseltamivir treatment of influenza in children. | Q32064242 | ||
| Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses | Q36170672 | ||
| Duration of influenza A virus shedding in hospitalized patients and implications for infection control | Q36969238 | ||
| Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada | Q37055208 | ||
| Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis | Q37955413 | ||
| Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial | Q38500366 | ||
| Influenza is a major contributor to childhood pneumonia in a tropical developing country | Q38922422 | ||
| P433 | issue | 2 | |
| P921 | main subject | Bangladesh | Q902 |
| urbanization | Q161078 | ||
| oseltamivir | Q211509 | ||
| placebo | Q269829 | ||
| P304 | page(s) | 109-118 | |
| P577 | publication date | 2013-11-22 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial | |
| P478 | volume | 14 |
| Q38686645 | A Genomic Signature of Influenza Infection Shows Potential for Presymptomatic Detection, Guiding Early Therapy, and Monitoring Clinical Responses. |
| Q30396994 | Antiviral Medications in Seasonal and Pandemic Influenza |
| Q57094433 | Antiviral treatment for outpatient use during an influenza pandemic: a decision tree model of outcomes averted and cost-effectiveness |
| Q36396691 | Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination |
| Q36899991 | Association of Oseltamivir Treatment With Virus Shedding, Illness, and Household Transmission of Influenza Viruses |
| Q90187064 | Baloxavir marboxil in Japanese pediatric patients with influenza: safety and clinical and virologic outcomes |
| Q41932743 | Commentary: A Historical Review of Centers for Disease Control and Prevention Antiviral Treatment and Postexposure Chemoprophylaxis Guidance for Human Infections With Novel Influenza A Viruses Associated With Severe Human Disease |
| Q47552532 | Containing influenza outbreaks with antiviral use in long-term care facilities in Taiwan, 2008-2014. |
| Q89782718 | Cost Effectiveness and Budget Impact Analyses of Influenza Vaccination for Prisoners in Thailand: An Application of System Dynamic Modelling |
| Q47578661 | Duration of viral shedding and factors associated with prolonged shedding among inpatients with influenza treated with oseltamivir: a prospective cohort study |
| Q41543622 | Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. |
| Q90402047 | Effects of Xinjiaxiangruyin on the TLR7 pathway in influenza virus-infected lungs of mice housed in a hygrothermal environment |
| Q40264783 | Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trial |
| Q47397356 | Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials |
| Q34660518 | Efficacy and safety of clearing heat and detoxifying injection in the treatment of influenza: a randomized, double-blinded, placebo-controlled trial |
| Q36156692 | Factors associated with clinical outcome in 25 patients with avian influenza A (H7N9) infection in Guangzhou, China |
| Q41499087 | Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial |
| Q41019102 | Impact of Prompt Influenza Antiviral Treatment on Extended Care Needs After Influenza Hospitalization Among Community-Dwelling Older Adults |
| Q28537982 | Impact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling study |
| Q40131070 | Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh |
| Q38774410 | Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza |
| Q60918080 | Influenza-induced rhabdomyolysis |
| Q30239895 | Japanese Surveillance Systems and Treatment for Influenza |
| Q33698075 | Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART |
| Q30374549 | Neuraminidase inhibitor therapy in a military population. |
| Q91989907 | Neuraminidase inhibitors for influenza-like illness in primary care |
| Q30370599 | Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. |
| Q38361244 | Optimizing antiviral therapy for influenza: understanding the evidence |
| Q47662382 | Oseltamivir Treatment of Influenza in Children. |
| Q91989917 | Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial |
| Q41412365 | Oseltamivir reduces clinical illness in households in Bangladesh |
| Q34460803 | Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials |
| Q38555260 | Point-of-care testing for respiratory viruses in adults: The current landscape and future potential |
| Q42051056 | Prevention and control of influenza in children during the 2016-2017 seasonal epidemic |
| Q57930420 | Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies |
| Q40275964 | Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh |
| Q91910138 | Seasonal Human Influenza: Treatment Options |
| Q30377019 | Sensitivity of the Quidel Sofia Fluorescent Immunoassay Compared With 2 Nucleic Acid Assays and Viral Culture to Detect Pandemic Influenza A(H1N1)pdm09. |
| Q94545219 | The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses |
| Q41589233 | The Mechanisms for Within-Host Influenza Virus Control Affect Model-Based Assessment and Prediction of Antiviral Treatment |
| Q57093751 | Timely Antiviral Administration During an Influenza Pandemic: Key Components |
| Q49980944 | Update: Influenza Activity - United States, October 1, 2017-February 3, 2018. |
| Q35974465 | Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season |
| Q21559446 | Use of neuraminidase inhibitors for rapid containment of influenza: a systematic review and meta-analysis of individual and household transmission studies |
| Q30249134 | Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis |
Search more.